Clinical Advances in Stem Cell Research Prices*
(USD)
Price without annual meeting registration
 $325
   
When bundled with Annual Meeting registration  
ISSCR Trainee Member $245
ISSCR Member $255
ISSCR Nonmember $265
   
When bundled with Annual Meeting and Workshop on Clinical Translation registration  
ISSCR Trainee Member  $215
ISSCR Member  $222
ISSCR Nonmember  $230
*Save 15% by bundling the CASC with ISSCR 2017 and the Workshop on Clinical Translation (WCT).

To register for the workshop only or bundled with ISSCR registration, click "Register Now."  

 


$245

PRE-MEETING EDUCATION

Clinical Advances in Stem Cell Research (CASC)

Tuesday, 13 June, 2017, 13:00 - 17:00
Room 253A, 253B, or 253C, Boston Convention and Exhibition Center

New this year, the Clinical Advances in Stem Cell Research (CASC) is a half-day program held the day before the ISSCR 2017 Annual Meeting. In disease-focused tracks, leaders in current and translational therapies will explore the current clinical landscape, advances in cell therapies, and how stem cell research is being applied in the clinic. The three independent tracks, held in parallel, will each have a separate focus: immuno-oncology, neurodegenerative diseases, and ocular indications. See below for more information.

Who Should Attend?

Physicians, physician-scientists or others working in oncology, neurodegeneration, and the eye, with an interest in understanding the successes and challenges in moving cell therapies into the clinic for the respective disease area. 

Attendees can register for one of the following CASC sessions: 

Neurodegenerative diseases

Confirmed speakers include

  • Claire Henchcliffe MD, DPhil  Weill Cornell Parkinson’s Disease & Movement Disorders Institute 
  • Roger Barker, MRCP, PhD  University of Cambridge
  • Lorenz Studer, MD  Memorial Sloan Kettering Cancer Center
  • Vivian Tabar, MD  Memorial Sloan Kettering Cancer Center

Final agenda for each session and confirmed speakers will be posted when available.


Ocular indications

Confirmed speakers include

  • Kapil Bharti, PhD, National Eye Institute, U.S. 
  • Michael Young, PhD, Schepens Eye Research Institute, U.S. 
  • Kang Zhang, MD PhD, University of California, San Diego, U.S. 
  • Hardy Kagimoto, MD, Healios, K. K., Japan

Final agenda for each session and confirmed speakers will be posted when available.

Immuno-oncology diseases

Confirmed speakers include

  • Marcela Maus, MD, PhD Massachusetts General Hospital
  • Helen Heslop, MD, Baylor College of Medicine
  • Carl June, MD, University of Pennsylvania

Final agenda for each session and confirmed speakers will be posted when available.


Venue Information

Boston Convention and Exhibition Center

415 Summer Street
Boston, MA 02210 USA
near the South Boston waterfront